SINGULAIR 10 mg, film-coated tablet 28 tablets
Brand page: Singulair (montelukast) — all forms and strengths in France
Active ingredients: Montelukast, Montelukast sodium
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- SINGULAIR 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide PVC-Aluminium de 28 comprimé(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67128676CIP74902834CIP133400949028344Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MONTÉLUKAST ACIDEcomprimé | 10 mg · un comprimé | FT |
| MONTÉLUKAST SODIQUEcomprimé | 10,4 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.